Vanguard Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$37.6M Buy
1,329,644
+154,119
+13% +$3.93M ﹤0.01% 2049
2026
Q2
$29.9M Sell
1,175,525
-37,168
-3% -$778K ﹤0.01% 2223
2026
Q1
$24.2M Buy
+1,212,693
New +$28.6M ﹤0.01% 2236

Other funds holding KMTS

Vanguard Capital Management's KMTS Position: Q3 2026 in Review

Vanguard Capital Management increased its Kestra Medical Technologies (KMTS) stake by 13% in Q3 2026, buying an estimated $3.93M and bringing the position to 1,329,644 shares worth $37.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2049.

Vanguard Capital Management first reported a position in KMTS in Q1 2026 and has held it in 3 quarters since. 122 funds tracked by Wall St. Rank hold KMTS as of Q3 2026.

  • Vanguard Capital Management held 1,329,644 shares of Kestra Medical Technologies worth $37.6M as of Q3 2026.
  • Vanguard Capital Management bought 154,119 Kestra Medical Technologies shares in Q3 2026, an estimated $3.93M.
  • Kestra Medical Technologies made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2049 holding.
  • Vanguard Capital Management first reported a position in Kestra Medical Technologies in Q1 2026 and has held it in 3 quarters since.
  • 122 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.